← Back to home

SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE)

Clinical trials for SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE) explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE) trials appear

Sign up with your email to follow new studies for SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New oral drug targets Cancer's growth engine in advanced tumours

Disease control Completed

This trial investigates an experimental oral drug, LY3143921 hydrate, which blocks a protein called Cdc7 that cancer cells need to divide. It is being tested in adults with advanced solid tumours, including colorectal, ovarian, lung, and pancreatic cancers, that have not responde…

Matched conditions: SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE)

Phase: PHASE1 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC

SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE)

Get alerted when new SQUAMOUS CARCINOMA OF THE HEAD AND NECK (HUMAN PAPILLOMAVIRUS (HPV) NEGATIVE) trials appear

New oral drug targets Cancer's growth engine in advanced tumours